Tag Archives: Lancet

India’s patent laws, public health response without public healthcare and bridging the Global Fund gap . . .

By on .

India’s patent laws: This Lancet special report on legal challenges by Bayer and Novartis to applications of India’s Patents Act provides a link to the 2010 United Nations Development Program’s report on the nation’s efforts to supply affordable HIV treatment in the context of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). It […]

Alarming but not surprising drug-resistant TB rates, survival sex, “a kind of truce,” and more . . .

By on .

Resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: This Lancet article looking at rates of  resistance to second line anti-tuberculosis drugs in Estonia, Latvia, Peru, Phillipines, Russia, South Africa, South Korea and Thailand, put numbers on a situation already known: tuberculosis is growing harder to cure. Following a June New England […]

Drug maker seeks approval for use against multidrug-resistant tuberculosis

By on .

Makers of an investigational tuberculosis drug that has been urged for “compassionate use” approval in South Africa have applied to the European Medicines Agency to market the medicine as part of a combination therapy for multidrug-resistant tuberculosis. “If approved, bedaquiline could be one of the first drugs with a new mechanism of action for tuberculosis […]

Lessons learned, lessons yet to be learned, Lancet’s MSM series, tuberculosis as kindling — HIV as the match, and more . . .

By on .

JAIDS all-PEPFAR supplement is free online and gives a past, present, future look at the President’s Emergency Plan For AIDS Relief as a historic effort that can still look forward to its greatest accomplishments. While the emphasis is on the program’s successes and a pre-AIDS 2012 panel discussion was light on the “lessons learned” from […]

Lancet Series Showcases Challenges, Promise in the Fight Against TB

By on .

Today, The Lancet launched an impressive new series of articles on the global tuberculosis epidemic, which claims 1.8 million lives every year. The Lancet articles note that TB is a leading cause of death in people in the most economically productive age-groups. The series highlights scale up of treatment and diagnoses, drug-resistant TB, and HIV/TB […]

Link Between Maternal Mortality & HIV "Laid Bare"

By on .

The Lancet today published a new analysis of maternal mortality data, in which the authors document greater progress in reducing maternal deaths than previous examinations. They also highlight the role of HIV in preventing even more significant gains in saving mother’s lives. The authors estimate there were 342,900 maternal deaths globally in 2008, down from […]

Biggest Threat to PEPFAR? Its Success, says Lancet Commentary

By on .

Most global AIDS advocates would agree that PEPFAR is at a critical juncture, mainly because of fears that Congress and the Obama administration are set to pull back from the program in favor of a new push on maternal and child health and health system strengthening. But in an interesting commentary in the Lancet today, […]

Lancet Articles Fire Up Fresh Debate Over Global Health Programs

By on .

The long-simmering debate over the impact of disease-specific programs on health-system strengthening may have just reached a boil. Today’s Lancet features an in-depth exploration of the impact of global health programs, particularly those aimed at tackling HIV/AIDS, tuberculosis and malaria. The debate has gained steam in recent weeks, since the White House announced its new […]

ART, Sooner Not Later

By on .

A new study suggests that HIV infected patients should start antiretroviral treatment earlier.   Here’s the editor’s note accompanying the article in today’s online version of the Lancet:   “When to start antiretroviral treatment has been a problem for physicians dealing with patients with HIV infection. Most commonly the decision is based on CD4 counts, […]